Tradestie Institutional Equity Comparison Engine

ABOS vs ASTL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ASTL Overall Edge

ASTL Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Algoma Steel Group Inc. Common Shares (ASTL) driven by superior Valuation, Momentum & Technical while ABOS counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, ABOS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ASTL at 9.1x Forward P/E and -63.3% operating margin (-52.4% YoY). In options structure, ABOS sits in UNCLASSIFIED (41st %ile IV; Dealer Gamma Walls on Pro) against ASTL sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ASTL
ABOS N/M vs ASTL 9.1x Fwd P/E
Growth & Margin Winner ABOS
Op Margin 0.0% vs -63.3% ยท YoY +0.0% vs -52.4%
Momentum & Technical Winner ASTL
1Y -87.6% vs +42.0% ยท 52W Pos 1% vs 70%
Options & Structure Winner ABOS
UNCLASSIFIED (41st %ile IV) vs CONSOLIDATION (15th %ile IV)
ABOS NASDAQ
Acumen Pharmaceuticals, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.21
-0.97% 1D
Market Cap $15.5M
1M Return -87.92%
1Y Return -87.64%
Forward P/E N/M
Unified AI Score
49.5 / 100 HOLD
Tech 55.0 Fund 58.0 Flow 68.0 Mom 55.0
ASTL NASDAQ
Algoma Steel Group Inc. Common Shares
Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens)
$5.08
-5.13% 1D
Market Cap $575.9M
1M Return +23.12%
1Y Return +42.04%
Forward P/E 9.1x
Unified AI Score
31.5 / 100 SELL
Tech 8.0 Fund 35.0 Flow 57.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABOS -87.64% ASTL +42.04% Spread: +129.68 pp (ASTL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABOS TTM Op. Margin: 0.0% ASTL TTM Op. Margin: -63.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABOS vs ASTL. Trailing 12-month operating profitability (ABOS 0.0% vs ASTL -63.3%) and valuation multiples (ABOS N/M vs ASTL 9.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABOS (4) vs ASTL (6)
Institutional Metric ABOS ASTL Criterion Row Winner
Market Capitalization Scale $15.5M $575.9M Larger Scale ASTL
Trailing P/E Ratio Valuation N/M 9.1x Lower Multiple ASTL
Forward P/E Ratio Valuation N/M 9.1x Lower Multiple ASTL
Revenue Growth (YoY) Growth +0.0% -52.4% Higher Growth ABOS
Operating Margin (TTM) Profitability 0.0% -63.3% Higher Margin ABOS
Net Profit Margin Profitability 0.0% -59.1% Higher Margin ABOS
Return on Equity (ROE) Capital Efficiency -162.7% -139.8% Higher ROE ASTL
52-Week Range Position Momentum 1% ($0โ€“$4) 70% ($3โ€“$6) Stronger Trend ASTL
Beta / 30D Volatility Risk Regime 2.63ฮฒ ยท 327% Vol 1.65ฮฒ ยท 66% Vol Lower Realized Risk ASTL
Unified Institutional Score Composite Signal 49.5 / 100 (HOLD) 31.5 / 100 (SELL) Higher Composite ABOS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABOS vs ASTL Buy Guide
ABOS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 41st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ASTL CONSOLIDATION
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live ASTL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABOS nor ASTL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.